Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice

Journal of Endocrinology

Volumn 163, Issue 2, 1999, Pages 229-234

  Holstad, M ^a   Sandler, S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CYTOKINE; DNA; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOSE; INSULIN; INTERLEUKIN 1; PROLACTIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; STATISTICAL PARAMETERS;

EID: 0032719397     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1630229     Document Type: Article

References (30)

1. Adorini L, Guery JC & Trembleau S 1996 Manipulation of the TH1/TH2 cell balance: an approach to treat human autoimmune diseases? Autoimmunity 23 53-68.
2. Atkison PR, Mahon JL, Dupre J, Stiller CR, Jenner MR, Paul TL & Momah CI 1990 Interaction of bromocriptine and cyclosporin in insulin dependent diabetes mellitus: results from the Canadian open study. Journal of Autoimmunity 3 793-799.
3. Bateman A, Singh A, Kral T & Solomon S 1989 The immunehypothalamic-pituitary-adrenal axis. Endocrine Reviews 10 92-112.
4. Berczi I 1993 The role of prolactin in the pathogenesis of autoimmune disease. Endocrine Pathology 4 178-195.
5. Berczi I 1997 Pituitary hormones and immune function. Acta Paediatrica 423 70-75.
6. Brelje TC, Scharp DW, Lacy PE, Ogren L, Talamantes F, Robertson M, Friesen HG & Sorenson RL 1993 Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132 879-887.
7. Durant S, Alves V, Coulaud J, El Hasnaoui A, Dardenne M & Homo-Delarche F 1995 Attempts to pharmacologically modulate prolactin levels and type 1 autoimmune diabetes in the non-obese diabetic (NOD) mouse. Journal of Autoimmunity 8 875-885.
8. El-Denshary EE, Ismail NA, Gagerman E, Sehlin J & Taljedal IB 1982 Bromocriptine and insulin secretion. Bioscience Reports 2 115-116.
9. Ferrari C, Boghen M & Paracchi A 1983 Thyroid autoimmunity in hyperprolactinemic disorders. Acta Endocrinologica 104 35-41.
10. Gala RR 1991 Prolactin and growth hormone in the regulation of the immune system. Proceedings of the Society for Experimental Biology and Medicine 198 513-527.
11. Hawkins TA, Gala RR & Dunbar JC 1994 Prolactin modulates the incidence of diabetes in male and female NOD mice. Autoimmunity 18 155-162.
12. Heding LG 1972 Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8 260-266.
13. Hinegardner RT 1971 An improved fluorometric assay for DNA. Analytical Biochemistry 39 197-201.
14. Holstad M & Sandler S 1993 Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity 15 311-314.
15. Jansson L & Sandler S 1988 The influence of cyclosporin A on the vascular permeability of the pancreatic islets and on diabetes induced by multiple low doses of streptozotocin in the mouse. Virchows Archiv A Pathological and Anatomical Histopathology 412 225-230.
16. Kolb-Bachofen V, Epstein S, Kiesel U & Kolb H 1988 Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37 21-27.
17. Like AA & Rossini AA 1976 Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193 415-417.
18. Neidhart M 1998 Prolactin in autoimmune diseases. Proceeding of the Society of Experimental Biology and Medicine 217 408-419.
19. Parrott RF & Goode JA 1993 Central effects of naloxone and selected opioid agonists on cortisol and prolactin secretion in non-stressed sheep. General Pharmacology 24 101-103.
20. Rabinovitch A 1993 Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Reviews 2 215-233.
21. Rabinovitch A 1994 Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 43 613-621.
22. Reber PM 1993 Prolactin and immunomodulation. American Journal of Medicine 95 637-644.
23. Sandler S, Andersson A & Hellerstrom C 1987 Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis and oxidative metabolism of rat pancreatic islets. Endocrinology 121 1424-1431.
24. Sinha YN, Salocks CB & VanderLaan WP 1976 A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice. Hormone and Metabolic Research 8 332-336.
25. Sorenson RL, Brelje TC & Roth C 1993 Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 133 2227-2234.
26. Spangelo BL, Hall NR, Ross PC & Goldstein AL 1987 Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 14 11-20.
27. Stout LE, Svensson AM & Sorenson RL 1997 Prolactin regulation of islet-derived INS-1 cells: characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 138 1592-1603.
28. Velkeniers B, Dogusan Z, Naessens F, Hooghe R & Hooghe-Peters EL 1998 Prolactin, growth hormone and the immune system in humans. Cellular and Molecular Life Sciences 54 1102-1108.
29. Walker SE, Allen SH & McMurray RW 1993 Prolactin and autoimmune disease. Trends in Endocrinology and Metabolism 4 147-151.
30. Zhu XH, Zellweger R Wichmann MW, Ayala A & Chaudry IH 1997 Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis. Cytokine 9 437-446.